The Top Small Cap Performers for May 7, 2019

By: Ian Cooper
11:09 05/07/2019

Some of the best performing small cap stocks for Monday, May 6, 2019 included:

Cohu Inc. (COHU)

At the moment, shares of COHU are up 27%, or $4.18 on three times average volume after an upgrade from a hold to buy rating at Stifel Nicolaus. The firm has a price target of $22. Following the company’s latest earnings results, analysts are confident that fundamentals have finally bottomed out, with a recovery forming.

SolarEdge Technologies (SEDG)

Shares of SEDG are up 19.4%, or $8.52 on the day on volume of nearly 3.5 million shares (average volume is 588,949). All after the company posted a Q1 profit of $19 million, or 39 cents per share on revenue of $271.9 million. That beat estimates for $265.4 million.

Bridgeline Digital Inc. (BLIN)

BLIN is up 31.4%, or $1.94 on very heavy volume of 8.8 million shares, as compared to daily average volume of 130.700. All after announcing that a global biopharmaceutical company will continue to leverage its OrchestraCMD to power its mission-critical sites.

One of the largest license holders of OrchestraCMS renewed their Website Channel License for a three-year license term valued at nearly $700,000. This renewal comes on the heel of the largest license renewal of OrchestraCMS being executed in December of 2018 also for a three-year term. As a result of these license agreements renewals, over one third of the OrchestraCMS recurring license revenue is now committed to three-year license renewals.

With the OrchestraCMS Website Channel License, users can power unlimited, global digital experiences across three regional Salesforce orgs. The license includes an Amazon s3 Webservice Connector and Premier and Critical 24-7 support. This customer is a publicly-traded, global company that manufactures prescription pharmaceuticals and biologics across several therapeutic areas. The marketing and technology teams of the biopharmaceutical company use the OrchestraCMS platform to power multiple digital properties globally for publishing pharmaceutical guidance, compliance and regulatory information.

This article has been provided by a PennyStockTitans contributor. All content submitted by this author represent their personal opinions, and should be considered as such for entertainment purpose only. All opinions expressed are those of the writer, and may not necessarily represent fact, opinions, or bias of PennyStockTitans.